MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'ernst'. Sat, 03 Sep 2011 02:28:15 +0100 http://www.medworm.com/index.php?rid=4055912&cid=t_102831_136_f&fid=35302&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FWhitePebble%2F%7E3%2FRCSUnj2I7Rk%2F The camera doesn’t make a bit of difference.  All of them can record what you are seeing.  But, you have to SEE. — Ernst Haas via Photography Quick Tip 3 ~ the Rule of Thirds in Composition « Everything Neat. Filed under: qotd Tagged: camera, Ernst Haas, Photography, qotd (Source: white pebble) white pebble blogs http://www.medworm.com/rss/comments.php?id=4055912 Mon, 11 Oct 2010 01:52:48 +0100 4055912 http://www.medworm.com/index.php?rid=3350239&cid=t_102831_87_f&fid=34595&url=http%3A%2F%2Fnhsblogdoc.blogspot.com%2F2010%2F03%2Fquacktitioner-royals-quack.html Dr Michael Dixon OBE is a GP in Devon, a devotee of homeopathy, and medical director of the Prince's Foundation for Integrated Health. He has just launched a vicious attack on the much respected Professor Edzard Ernst. Ernst is the Professor of Complementary Medicine at the Peninsula Medical School. The champagne corks were popping in quackland when it was announced that a chair in complementary medicine had been funded. The celebration soon stopped when, rather then setting up a shop to flog patent medicines,  Ernst began to use rigorous scientific techniques to analyse numerous alternative "therapies". Much of this was described in the book Ernst co-authored with Simon Singh, "Trick or Treatment - Alternative Medicine on Trial". They looked at homeopathy, acupuncture and many other ... NHS Blog Doctor blogs http://www.medworm.com/rss/comments.php?id=3350239 Wed, 10 Mar 2010 13:45:00 +0100 3350239 http://www.medworm.com/index.php?rid=3262892&cid=t_102831_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FB5TX9ZqEuRo%2F With old business models broken and industry in transition, the future will hinge on just how well drugmakers adapt to new technologies. Patients, for instance, can and will want to manage their health records with such devices as smart phones and hospitals and payers will comb through electronic records, which means pharma will lose exclusive control over outcomes data. These are among the findings in a new report from Ernst & Young consultants, who also believe pharma will have to consider alliances with food companies in emerging markets for help in managing supply chains. “Innovation is no longer just about the product — it now encompasses how you do business, who you do business with and how you mobilize your resources to contribute to healthy outcomes for patients.” says ... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3262892 Thu, 11 Feb 2010 13:46:48 +0100 3262892 http://www.medworm.com/index.php?rid=2705293&cid=t_102831_133_f&fid=35096&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAutismVox%2F%7E3%2Fi2dQ7OqTK8I%2F The latter part of our Q.-and A. with Ernst VanBergeijk, associate dean and executive director of the New York Institute of Technology’s Vocational Independence Program (VIP), a certificate program for adult students with learning disabilities. Q: Do you know of any other programs like it in the country? EVB: There are many great programs that provide transitional services to individuals with autism spectrum disorders and other disabilities. However, very few are college based, i.e., are a part of a college like VIP. Q:How are these programs run? EVB: Most are based in an apartment complex and affiliated with either a community college or a 4-year college. That means the employees of the program work for a private entity and are not employees of the college. The employees of the affili... Autism Vox blogs http://www.medworm.com/rss/comments.php?id=2705293 Sun, 16 Aug 2009 19:28:05 +0100 2705293 http://www.medworm.com/index.php?rid=2703930&cid=t_102831_133_f&fid=35096&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAutismVox%2F%7E3%2FgIFr6qLdGZo%2F Q.-and A. with Ernst VanBergeijk, associate dean and executive director of the New York Institute of Technology’s Vocational Independence Program (VIP), a certificate program for adult students with learning disabilities . Q: How did VIP begin? EVB: In 1987, NYIT President Matthew Schure realized that individuals with physical and learning disabilities were not offered the same access to opportunity as their non-disabled peers. Meanwhile, Neal Nelson, a local football coach and originator of the Weight Watchers children’s camps, and two colleagues approached President Schure with the idea of a summer program for teens with disabilities. The group began writing a curriculum for the summer program. By the time they were finished with the task, not only had they created a seven-week ... Autism Vox blogs http://www.medworm.com/rss/comments.php?id=2703930 Sat, 15 Aug 2009 21:47:40 +0100 2703930 http://www.medworm.com/index.php?rid=1478217&cid=t_102831_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F300683065%2F In Texas, an appeals court scrapped a $26 million verdict stemming from the first Vioxx trial by finding no evidence that Robert Ernst suffered a fatal heart problem from a blood clot triggered by the painkiller. He died in 2001 after taking Vioxx for eight months, and his widow had won a $253 million verdict in 2005, although Texas punitive damage caps later cut that to about $26 million. Here is the Ernst decision, which Ernst lawyer Mark Lanier says he will appeal. And in New Jersey, a jury two years ago ordered Merck to pay John McDarby and his wife $13.5 million in punitive damages, although that didn’t include compensatory damages, which amounts to $4.5 million, plus about $600,000 in interest, and still stands. That’s because the NJ appeals court ruled there was no preem... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1478217 Thu, 29 May 2008 14:37:33 +0100 1478217 http://www.medworm.com/index.php?rid=1454778&cid=t_102831_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F294206655%2F In fact, financing topped $21.3 billion for US biotechs last year, the $5.5 billion contributed by venture capital firms beat the record set of $39.4 million in 2000, according to Ernst & Young’s annual financial report card on the industry. Whether this pace will continue is less certain, Scott Morrison, E&Y’s US life sciences director, tells The San Francisco Chronicle, because new product approvals will slow as regulators scrutinize applications. And drug prices may face more pressure in a political environment focused on health care reform and the federal budget deficit. Beyond that, constriction in the larger capital markets has finally started to affect biotech companies this year. “Biotech has not been immune from the ills of the subprime mortgage meltdow... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1454778 Tue, 20 May 2008 11:41:22 +0100 1454778 http://www.medworm.com/index.php?rid=812278&cid=t_102831_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F146370555%2F Nearly three years after Merck withdrew its Cox-2 painkiller over links to heart attacks and strokes, none of the approximately 45,000 people suing the drugmaker have collected a penny, including the Texas widow who was awarded $26 million in the first Vioxx trial. Why? Lengthy appeals, a huge case load, and Merck’s determination to fight each and every case, a strategy the drugmaker’s general counsel and newly named No. 2 exec, Ken Frazier, vowed to pursue from the start. The effort “seems to have worked quite well,” Peter Schuck, a Yale Law School professor who specializes in complex litigation, tells The New York Times. “They have discouraged the plaintiffs’ bar from litigating these cases.” Wall Street now believes Merck’s ultimate Vioxx liability is... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=812278 Tue, 21 Aug 2007 04:36:29 +0100 812278 http://www.medworm.com/index.php?rid=478802&cid=t_102831_87_f&fid=34882&url=http%3A%2F%2Fbreathspakids.blogspot.com%2F2007%2F03%2Fdiscouraging-news-from-review-of.html When people want you to consider rewriting "textbooks in physics, pharmacology and chemistry", you hope that they have good evidence behind it and some workable hypotheses with which to replace these erroneous and out-moded doctrines that have maintained a stranglehold in scientific and medical education. Sadly, it doesn't seem as if either the evidence or workable replacement mechanisms of action will be available any time soon so 'we mun dree oor wyrd' and hope for a paradigm shift to happen before error leads us into catastrophe.The House of Lords has appointed a committee to investigate allergy and intolerance in the UK. The Committee is investigating some important issues with implications for public health and public policy so I was hopeful that the written submissions and oral heari... Breath Spa for Kids blogs http://www.medworm.com/rss/comments.php?id=478802 Mon, 12 Mar 2007 13:47:00 +0100 478802